Quick Answer
TELA Bio, Inc. reported Long-Term Debt of $55.65 million for fiscal year 2025.
TELA Bio, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $55.65M | +35.3% |
| 2024 | $41.12M | +1.5% |
| 2023 | $40.52M | +1.5% |
| 2022 | $39.92M | +26.8% |
| 2021 | $31.49M | +2.2% |
| 2020 | $30.83M | +1.9% |
| 2019 | $30.24M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $41.49M | +1.3% | +9.0% |
| June 30, 2025 | $38.05M | -6.8% | -7.8% |
| March 31, 2025 | $41.27M | +1.5% | +0.4% |
| December 31, 2024 | $41.12M | +1.5% | +0.4% |
| September 30, 2024 | $40.97M | +1.5% | +0.4% |
| June 30, 2024 | $40.82M | +1.5% | +0.4% |
| March 31, 2024 | $40.66M | +1.5% | +0.4% |
| December 31, 2023 | $40.52M | +1.5% | +0.4% |
- TELA Bio, Inc. showed an increase of +35.3% in Long-Term Debt compared to the prior fiscal year.
- Over the 2019–2025 period, TELA Bio, Inc.’s long-term debt has grown by 84.0% (from $30.24 million to $55.65 million).
- The most recent figure is from TELA Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: